Enhertu for metastatic breast cancer patients

That this House recognises the recent changes to NICE’s cost effectiveness threshold, which could facilitate better access to new medicines; expresses concern that Enhertu, a treatment for people with incurable HER2-low metastatic breast cancer, remains unavailable to patients on the NHS in England; welcomes Breast Cancer Now's Enhertu Now campaign, supported by METUPUK and Make 2nds Count; and urges pharmaceutical companies Daiichi Sankyo and AstraZeneca, NHS England and NICE to reach a deal to make Enhertu available to those who urgently need it to give them more time to live.

• Clive Jones Sponsor
• Vikki Slade
• Mr Will Forster
• Jess Brown-Fuller
• Jim Shannon
• Wera Hobhouse
• Andrew George
• Gideon Amos
• Mr Lee Dillon
• Dr Roz Savage
• Sorcha Eastwood
• Cameron Thomas
• Sarah Dyke
• Pippa Heylings
• Mr Paul Kohler
• Mary Kelly Foy